Allogeneic stem cell transplantation in AML - immunosuppression with Rapamycin as alternative to calcineurin inhibitors

被引：0
|
作者：
Reibke, R. [1 ]
Franko, L. [1 ]
Tischer, J. [1 ]
Kolb, H-J [2 ]
机构：
[1] Univ Hosp Munich, Dept Internal Med 3, Munich, Germany
[2] Tech Univ Munich, Dept Internal Med 3, Munich, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：210 / 211
页数：2
相关论文
共 50 条
  • [31] Haemophagocytic syndrome in relapsed AML patients after allogeneic stem cell transplantation
    Keklik, C. P. M.
    Akyol, G.
    Canoz, O.
    Sivgin, S.
    Kaynar, L.
    Eser, B.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S528 - S529
  • [32] Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML
    Fuse, Kyoko
    Masuko, Masayoshi
    Mizuno, Shohei
    Harada, Kaito
    Uchida, Naoyuki
    Doki, Noriko
    Fukuda, Takahiro
    Tanaka, Masatsugu
    Ozawa, Yukiyasu
    Ikegame, Kazuhiro
    Eto, Tetsuya
    Kanda, Yoshinobu
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yanada, Masamitsu
    BLOOD, 2020, 136
  • [33] Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma
    H Shimizu
    T Saitoh
    M Tanaka
    T Mori
    T Sakura
    N Kawai
    Y Kanda
    C Nakaseko
    S Yano
    H Fujita
    S Fujisawa
    S Miyawaki
    H Kanamori
    S Okamoto
    Leukemia, 2012, 26 : 2469 - 2473
  • [34] Impact of Cytogenetics on Outcome of AML after Allogeneic Hematopoietic Stem Cell Transplantation
    Gindina, Tatiana L.
    Mamaev, Nikolay N.
    Afanasyev, Boris V.
    Bondarenko, Sergey N.
    Alyanskiy, Alexander
    Slesarchuk, Olga
    Moiseev, Ivan S.
    Razumova, Svetlana V.
    Zubarovskaya, Lyudmila
    BLOOD, 2015, 126 (23)
  • [35] Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma
    Shimizu, H.
    Saitoh, T.
    Tanaka, M.
    Mori, T.
    Sakura, T.
    Kawai, N.
    Kanda, Y.
    Nakaseko, C.
    Yano, S.
    Fujita, H.
    Fujisawa, S.
    Miyawaki, S.
    Kanamori, H.
    Okamoto, S.
    LEUKEMIA, 2012, 26 (12) : 2469 - 2473
  • [36] DARTS, Bites and ADCs for the Treatment of AML and for Conditioning for Allogeneic Stem Cell Transplantation
    DiPersio, John F.
    Rettig, Mike
    Persaud, Steve
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S86 - S86
  • [37] Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation for AML With Down Syndrome
    Muramatsu, Hideki
    Sakaguchi, Hirotoshi
    Taga, Takashi
    Tabuchi, Ken
    Adachi, Souichi
    Inoue, Masami
    Kitoh, Toshiyuki
    Suminoe, Aiko
    Yabe, Hiromasa
    Azuma, Eichi
    Shioda, Yoko
    Ogawa, Atsushi
    Kinoshita, Akitoshi
    Kigasawa, Hisato
    Osugi, Yuko
    Koike, Kazutoshi
    Kawa, Keisei
    Kato, Koji
    Atsuta, Yoshiko
    Kudo, Kazuko
    PEDIATRIC BLOOD & CANCER, 2014, 61 (05) : 925 - 927
  • [38] Allogeneic stem cell transplantation for patients with AML and FLT-3 mutations
    Schleuning, M.
    Judith, D.
    Heshmat, M.
    Burlakova, I.
    Tschischka, S.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S274 - S275
  • [39] Allogeneic stem cell transplantation (SCT) for myelodysplastic syndrome and secondary AML.
    Schwerdtfeger, R
    Braeuninger, S
    Prumbaum, M
    Kreissig, C
    Baurmann, H
    BLOOD, 2000, 96 (11) : 364B - 364B
  • [40] Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine
    Graef, Thorsten
    Kuendgen, Andrea
    Fenk, Roland
    Zohren, Fabian
    Haas, Rainer
    Kobbe, Guido
    LEUKEMIA RESEARCH, 2007, 31 (02) : 257 - 259
12345